[1] Ghadiri A., A. Habermacher, and T. Peters. Neuroscience for Business, in Neuroleadership. Springer, 2012.
[2] Hakim A. and D.J. Levy. “A gateway to consumers’ minds: Achievements, caveats, and prospects of electroencephalography-based prediction in neuromarketing”. In: Wiley Interdisciplinary Reviews: Cognitive Science 10 (2 2019), e14185.
[3] Alvino L. et al. “Picking your brains: Where and how neuroscience tools can enhance marketing research”. In: Frontiers in neuroscience 14 (2020), p. 1221.
[4] Cherubino P. et al. “Consumer behaviour through the eyes of neurophysiological measures: State-of-the-art and future trends”. In: Computational intelligence and neuroscience (2019).
[5] Giannakakis G. et al. “Review on psychological stress detection using biosignals”. In: IEEE Transactions on Affective Computing (2019).
[6] Jobert M. et al. “Guidelines for the recording and evaluation of pharmaco-EEG data in man: the International Pharmaco-EEG Society (IPEG)”. In: Neuropsychobiology 66 (4 2012), pp. 201–220.
[7] Lozupone M. et al. “The role of biomarkers in psychiatry”. In: Reviews on biomarker studies in psychiatric and neurodegenerative disorders (2019), pp. 135–162.
[8] Muhammad Sayem A.S. et al. “Review on smart electro-clothing systems (SeCSs)”. In: Sensors 20 (3 2020), p. 587.
[9] Shimizu T. et al. “Real-time evaluation of driver cognitive loads based on multivariate biosignal analysis”. In: IEEE International Conference on Systems, Man, and Cybernetics (SMC) (2020).
[10] Varandas R. et al. “Automatic Cognitive Workload Classification Using Biosignals for Distance Learning Applications”. In: Doctoral Conference on Computing, Electrical and Industrial Systems-Springer (2021).
[11] Alcaniz and et al. M. “Autism spectrum disorder biomarkers based on biosignals, virtual reality and artificial intelligence”. In: Medicina 80 (2020), pp. 31–36.
[12] P. et al. Aric`o. “Passive BCI beyond the lab: current trends and future directions”. In: Physiological measurement 39 (8 2018), 08TR02.
[13] B. Bandelow and et al. “Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition”. In: The World Journal of Biological Psychiatry 18 (3 2017), pp. 162–214.
[14] Merideth C. The Impact of Neuro-Education Intervention Methods upon the Learning and Development of an Individual with Developmental Disabilities. University of Portland, 2021.
[15] Maron E. and D. Nutt. “Biological markers of generalized anxiety disorder”. In: Dialogues in clinical neuroscience 19 (2 2017), p. 147.
[16] Espino-D´ıaz and L. et al. “Creating Interactive Learning Environments through the Use of Information and Communication Technologies Applied to Learning of Social Values: An Approach from Neuro-Education”. In: Social Sciences 9 (5 2020), p. 72.
[17] Qureshi F. and S. Krishnan. “Wearable hardware design for the internet of medical things (IoMT)”. In: Sensors 18 (11 2018), p. 3812.
[18] Viviani G. and A. Vallesi. “EEG-neurofeedback and executive function enhancement in healthy adults: A systematic review”. In: Psychophysiology 58 (9 2021), e13874.
[19] Babu G.C. and S. Shantharajah. “Remote health patient monitoring system for early detection of heart disease”. In: International Journal of Grid and High Performance Computing (IJGHPC) 13 (2 2021), pp. 118–130.
[20] Ocampo Alvarado J.C. “On the neuro in neuroeducation: from psychologization to the neurologization of school”. In: Sophia, Colecci´on de Filosof´ıa de la Educaci´on 29 (2019), pp. 141–169.
[21] Zwaan L.A., D. Aiken, and R. Viljoen. “The role of neuroleadership in work engagement”. In: SA Journal of Human Resource Management 17 (1 2019), pp. 1–9.
[22] Jobert M. and M. Arns. “Pharmaco-EEG, Pharmaco-Sleep and EEG-Based Personalized Medicine”. In: Neuropsychobiology 72 (3-4 2015), pp. 137–138.
[23] Lebedev M.A. and M.A. Nicolelis. “Brain-machine interfaces: From basic science to neuroprostheses and neurorehabilitation”. In: Physiological reviews 97 (2 2017), pp. 767–837.
[24] Kuhlmann N. and C.A. Kadgien. Neuroleadership: Themes and limitations of an emerging interdisciplinary field. SAGE Publications Sage CA: Los Angeles, CA, 2018.
[25] Niculescu and A. et al. “Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs”. In: Molecular psychiatry 25 (8 2020), pp. 1651–1672.
[26] Kumar P.M. and U.D. Gandhi. “A novel three-tier Internet of Things architecture with machine learning algorithm for early detection of heart diseases”. In: Computers and Electrical Engineering 65 (2018), pp. 118–130.
[27] Howell Sabrina T., Niessner Marina, and Yermack David. In: Review of Financial Studies 33 (9 2020), pp. 3925–2974.
[28] Varatharajan, R., and et al. “Wearable sensor devices for early detection of Alzheimer disease using dynamic time warping algorithm”. In: Cluster Computing 21 (1 2018), pp. 681–690.
[29] Paul Wackerow. Ethereum ERC-20 TOKEN STANDARD. url: docs/standards/tokens/erc-20/.
[30] Kaylie Welykholowa et al. “Multimodal photoplethysmography-based approaches for improved detection of hypertension”. In: Journal of Clinical Medicine 9 (1-20 2020), pp. 3016–3025.
[31] Xiang and M.-Q. et al. “The effect of neurofeedback training for sport performance in athletes: A metaanalysis ”. In: Psychology of Sport and Exercise 36 (2018), pp. 114–122.
[32] H¨oller Y., C. Helmstaedter, and K. Lehnertz. “Quantitative pharmaco-electroencephalography in antiepileptic drug research”. In: CNS drugs 32 (9 2018), pp. 839–848.
Last modified 2mo ago
Export as PDF
Copy link